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Background: The neurotrophins nsrvs growth factor (NGF) and brain-derived neurotophic factor
(BDNF) is a family of polypeptides that play critical role during neuronal development, appear to
medial.rc protective role on neurorepair in ischemic stroke. Naturally in adult brain neurorepair process
consist of: angiogenesis, neurogenesis, and neuronal plasticity, it can also be stimulated by endogenous
neurorepair. tn this study we observed correlation between NGF and BDNF ischemic stroke patient's
onset: 7-30 and over 30 days. Methods: This is cross sectional study on 46 subjects aged 38 
- 
74 years
old with ischemic stroke from The lndonesian Central Hospital of Army Gatot Subroto Jakarta.
Diagnosis of ischemic stroke was made using clinical examination and magnetic resonance imaging
(MRI) by neurologist. Subjects were divi{ed into 2 groups based on stroke gnset: 7 
- 
30 days (Group
A: 19 subjects) and > 30 days (Group B: 27 Subjects). Serum NGF levels were measured with ELISA
method and BDNF levels were measured using multiplex method with Luminu Magpix. Results:
Levels of NGF and BDNF were significantly different between onset group A and B (NGF p: 0.022,
and BDNF p=0.008), with mean levels NGF in group A higher than group B, indicating that BDNF
levels is lower in group A than group B. There was no significant correlation between NGF and BDNF
levels in all groups. Conqlusion: The,variations in neurotrophic factor levels reflect an endogenous
attempt at neuroprotection against biochemical and molecular changes after ischemic stroke. NGF
represents an early marker of brain injury while BDNF recovery is most prominent during the fust 14
days after onsite but continuous for morqthan 30 days. There is no significant correlation between NGF
and BDNF in each goup.
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INTRODUCTION
Stroke is one of the biggest neurological
threats that causes disability in patient.
Epidemiological sfudies in' developing countries
showed significantly increased incident in 20 years.r
Efforts to develop thorapeutic strategies that are
applied after an ischemic stroke for triggering
recovery of function and stimulate neural plasticity
(newoplasticity) are applied in conjunction with
neurorehabilitation (neurorepair). 2
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Several sfroke studies indicate increased
levels of neurotrophic growth factors have a
protective role.3 Neurohophic factors are
endogenous molecules play a role in repair-
regeneration process such as axonal regeneration,
neurogenesis, and neuronal plasticity, in fact
protection against degeneration and lesions, that
could be critical for recovery after ischemic stroke.
The family of neurotrophins includes Nerve growth
factor (NGF) and Brain-derived neurotrophic factor
(BDNF).4
NGF is a neurotophic that support the
survival and differentiation of neuronss, lowering
the degeneration of nerve, and triggers nerve
regeneration.6 NGF is critical to the survival and
main0enance of neuron after cerebral hypoxia-
ischemia.T
Open access: www.balimedicaljournal.org and www.ojs.unud.ac.id 10
tsaltl"leti,oal/Jot*wafu (AoUMeD 2016, Vobump 5, Nt,mb?/ 2: 70-73
P-ISSN.2089 -1 180, E-ISSN,2302 -29 7+
BDNF is membcr of aneuronal growth factor
is the most widely neurotrophins excreted in the
central nervous system mature. BDNF works
through high affinity cgll surface receptors (TrkB).8
Maintaining the viability of the various types of
neurons and prevent neuronal death after cerebral
ischemia by activating intracellular protein kinase B,
MAPKs and ERKs.e
The aim of this study is to observe the
correlationbetweenNGF and BDNF in patients with
ischemic stroke with difference onset time.
MATERIALSAND METHODS
This is a cross-sectional study with 30 
- 
60
years old ischemic stroke subjects from The Central
Hospital of the Army (RSPAD) Gatot Subroto
Jalerta. Diagnosis of ischemic stroke were
determined by clinical examination and MRI.
Subjects were divided into 2 groups based on
onset time of sfioke. Group A are patient with onset
7 
- 
30 days and Group B are patient with onset more
than 30 days. Subject with a history of carcinom4
hematoma subdural, or other carcinom4 global'
ischemia, seizures, blood clotting disorders, and
could not conduct MRI were excluded.
Variable
Specimen collection
Blood were collected intravenously, serum
was generated stored frozen (at -21"C), and tested
for biom4rkers. NGF concentrations were measured
t'sing ELISA method and BDNF concentrations
were measured using multiplex method (Reagent
R&D no cat LXSAHM-03) with Luminex Magpix
instrument
Statisfical analysis
Sbtistical analysis was performed using
SPSS for Mac version 20 for normal disftibution
was amlyzed by Kolmogorov Smirnov and
differencb significance for each groups was
analyzed by t-test analysis. Meanwhile correlation
of NGF with BDNF anallzed by Pearson analysis.
RESULT :
We used 46 ischemic stroke subjects, which
divided onto 2 groups of: 19 subjects for group A,
27 subjects for group B. Characteristics ofsubjects
and the results of normality test data are shown in
Table l.
Min Max Mean * SD Median
Age (years)
BMI (kg/m)
SBP (mmHg)
DBP (mmHg)
BDNF (pgiml)
38.
t6.6 '
57, 
-
106
6,105
56.9 +9.43 56 0.658*31.7 24.6+3.21 23.5 0.160*
' 33,967 lg,ggg + 6,105 lg,32o 0.gg3r
NGF 4.35 9.67 5.89 * 0.81 5.75 0.244*
*Distribution assessment with Kolmogorov smirnovi@
120 86 * 13220 146125 85 0.223*140 0.3 1 1*
Independent
t-test
0.224
0.856
Differences BDNF andNGF levels on onset strokc
We found Lrvels of NGF and BDNF in table
2 significantly different between onset group A and
B (NGF p= 0.022, and BDNF p:0.008). We also
found mean levels NGF in group A higher than
group B whereas mean BDNF levels appear lower
in group A than group B. There is no significant
difference for variables age, BMI, Systolic, and
Diastolic between the groups onsel
Variable
SBP(mmHg)
DBP(mmHg)
88 r 16.9
145 + 30
83 +,9.6
t47 *20
Subjects Onset Group .
7 - 30 days after onset >30 days after onset
BMI (kglm) 24.7 *3.1 24.r r3.4 0.768
BDNF (pglml) 15,777 * 5,476 21,097 * 6,962 0.009*
NGF 6.21+ 1.0 5.66 + 0.54 0.022*
* Significantly independent t-test p<0.005
Table 1. General charac0eristics of
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Comparison mean of BDNF andNGF among
groups
Correlation between BDNF and NGF
Using Pearson correlation test, no such
significant correlation was found between NGF
and BDNF concentration in each subject group
Table 3. Correlation analysis Between BDNF and
NGF
Group Onset
ischemic cortex, NGF increased beginning at hour 4,
peaked at day 7, and returned almost to the sham
control level at day 14.' 1
After brain damage due to hypoxic ischemia,
elevated expression ofNGF plays a key role in the
response after the injury, and may have a beneficial
impact on the regenerative capacity of the injured
tissues.r2 The action of NGF in modulating the
cerebral tissue viability might be due to the role
exerted by NGF in favoring the biosynthesis of
doublecortin (DCX), a protein expressed by new
neurons after brain stroke.l3 Recent studies find
neuroprotective role of others neurofiophins' BDNF
is upregulated at very early stages during brain
ischemia, suggesting endogenous neuroprotective
mechanisms in viable neuronal networks.ra
BDNF levels were significant difference
between group A and B, with mean levels BDNF
level in group A lower than group B. Animal study
reported that BDNF secreted by human bone
marrow-derived MSCs (hBMSCs) was upregulated
at 7 days andsigatficantly increase expression at 14
days (15). The following process on survival neuron
and proliferatibn parenchymal cell increase
plasticity after 2-3 weeks.r6 BDNF induced
Microtubule-Associated Protein lB (MAPIB)
expression in the ischemic border zone and
synaptophysin expression within the contralateral
cortex 6 weeks after ischemia-I7
CONCLUSIONS
The variations in neurotophic factor levels
reflect an endogenous attempt at neuroprotection
against biochemical and molecular changes after
ischemic stroke. NGF represents an early marker of
brain injury while BDNF recovery is most
prominent during the first 14 days after onsite but
continues for more than 30 days. There is no
significant correlation between NGF and BDNF in
each group.
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